Ann: Benitec announces organisational restructure, page-54

Not so J8. See below from presentation on 24th April 2018:

""The study has a two-stage design which allows for stopping of the study based on either success or futility at the end of the first stage, after 12 patients have been enrolled and monitored through the primary outcome measure. This interim analysis is anticipated to occur around the end of the 2018 calendar year."'

https://hotcopper.com.au/threads/ann-clinical-program-update.4149781/?post_id=32645986#.WySgtvZuLIU

The share price will rise much earlier in anticipation.